632 related articles for article (PubMed ID: 31485019)
1. Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways.
Qian M; Wang S; Guo X; Wang J; Zhang Z; Qiu W; Gao X; Chen Z; Xu J; Zhao R; Xue H; Li G
Oncogene; 2020 Jan; 39(2):428-442. PubMed ID: 31485019
[TBL] [Abstract][Full Text] [Related]
2. Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction.
Xu J; Zhang J; Zhang Z; Gao Z; Qi Y; Qiu W; Pan Z; Guo Q; Li B; Zhao S; Guo X; Qian M; Chen Z; Wang S; Gao X; Zhang S; Wang H; Guo X; Zhang P; Zhao R; Xue H; Li G
Cell Death Dis; 2021 Apr; 12(4):373. PubMed ID: 33828078
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression.
Li M; Xu H; Qi Y; Pan Z; Li B; Gao Z; Zhao R; Xue H; Li G
Oncogene; 2022 Oct; 41(41):4618-4632. PubMed ID: 36085418
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
Guo X; Qiu W; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Xue H; Li G
Oncogene; 2018 Aug; 37(31):4239-4259. PubMed ID: 29713056
[TBL] [Abstract][Full Text] [Related]
5. Exosomes derived from hypoxic glioma deliver miR-1246 and miR-10b-5p to normoxic glioma cells to promote migration and invasion.
Qian M; Chen Z; Guo X; Wang S; Zhang Z; Qiu W; Qi Y; Zhang S; Xu J; Zhao R; Xue H; Li G
Lab Invest; 2021 May; 101(5):612-624. PubMed ID: 33446893
[TBL] [Abstract][Full Text] [Related]
6. Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3.
Shen T; Miao S; Zhou Y; Yi X; Xue S; Du B; Tang C; Qu L; Fu D; Jia R; He H
Cell Commun Signal; 2022 Sep; 20(1):152. PubMed ID: 36153596
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic lung cancer cell-derived exosomal miR-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting IRF1.
Jin J; Yu G
World J Surg Oncol; 2022 Jul; 20(1):241. PubMed ID: 35897096
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic lung adenocarcinoma-derived exosomal miR-1290 induces M2 macrophage polarization by targeting SOCS3.
Gu J; Yang S; Wang X; Wu Y; Wei J; Xu J
Cancer Med; 2023 Jun; 12(11):12639-12652. PubMed ID: 37081748
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway.
Zhang W; Zheng X; Yu Y; Zheng L; Lan J; Wu Y; Liu H; Zhao A; Huang H; Chen W
Int J Biol Sci; 2022; 18(8):3209-3222. PubMed ID: 35637970
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
Ling HY; Yang Z; Wang PJ; Sun Y; Ju SG; Li J; Fu JX
Chem Biol Interact; 2022 Jan; 352():109779. PubMed ID: 34922904
[TBL] [Abstract][Full Text] [Related]
11. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
Dai Y; Wang S; Chang S; Ren D; Shali S; Li C; Yang H; Huang Z; Ge J
J Mol Cell Cardiol; 2020 May; 142():65-79. PubMed ID: 32087217
[TBL] [Abstract][Full Text] [Related]
12. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization.
Jang JY; Lee JK; Jeon YK; Kim CW
BMC Cancer; 2013 Sep; 13():421. PubMed ID: 24044575
[TBL] [Abstract][Full Text] [Related]
13. HMGB1 in exosomes derived from gastric cancer cells induces M2-like macrophage polarization by inhibiting the NF-κB signaling pathway.
Liu K; Wang H; Zhou J; Zhu S; Ma M; Xiao H; Ding Y
Cell Biol Int; 2024 Mar; 48(3):334-346. PubMed ID: 38105539
[TBL] [Abstract][Full Text] [Related]
14. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
[TBL] [Abstract][Full Text] [Related]
15. M2 macrophage-derived exosomal microRNAs inhibit cell migration and invasion in gliomas through PI3K/AKT/mTOR signaling pathway.
Yao J; Wang Z; Cheng Y; Ma C; Zhong Y; Xiao Y; Gao X; Li Z
J Transl Med; 2021 Mar; 19(1):99. PubMed ID: 33676540
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Periodontal Ligament Stem Cells Drive M1 Macrophage Polarization via Exosomal miR-143-3p-Mediated Regulation of PI3K/AKT/NF-κB Signaling.
Wang Y; Zhang X; Wang J; Zhang Y; Ye Q; Wang Y; Fei D; Wang Q
Stem Cells; 2023 Mar; 41(2):184-199. PubMed ID: 36520505
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma.
Bao L; Li X
Mol Cell Biochem; 2019 Oct; 460(1-2):67-79. PubMed ID: 31218569
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced exosomes facilitate lung pre-metastatic niche formation in hepatocellular carcinoma through the miR-4508-RFX1-IL17A-p38 MAPK-NF-κB pathway.
Jia W; Liang S; Lin W; Li S; Yuan J; Jin M; Nie S; Zhang Y; Zhai X; Zhou L; Ling C; Cheng B; Ling C
Int J Biol Sci; 2023; 19(15):4744-4762. PubMed ID: 37781522
[No Abstract] [Full Text] [Related]
19. miR-3184-3p enriched in cerebrospinal fluid exosomes contributes to progression of glioma and promotes M2-like macrophage polarization.
Xu H; Li M; Pan Z; Zhang Z; Gao Z; Zhao R; Li B; Qi Y; Qiu W; Guo Q; Zhang S; Fan Y; Zhao S; Wang S; Guo X; Deng L; Xue H; Li G
Cancer Sci; 2022 Aug; 113(8):2668-2680. PubMed ID: 35411604
[TBL] [Abstract][Full Text] [Related]
20. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis.
He Z; Wang J; Zhu C; Xu J; Chen P; Jiang X; Chen Y; Jiang J; Sun C
Cancer Lett; 2022 Nov; 548():215751. PubMed ID: 35718269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
